Exosomes: Outlook for Future Cell-Free Cardiovascular Disease Therapy
- PMID: 28936747
- DOI: 10.1007/978-981-10-4397-0_19
Exosomes: Outlook for Future Cell-Free Cardiovascular Disease Therapy
Abstract
Cardiovascular diseases are the number one cause of death globally with an estimated 7.4 million people dying from coronary heart disease. Studies have been conducted to identify the therapeutic utility of exosomes in many diseases, including cardiovascular diseases. It has been demonstrated that exosomes are immune modulators, can be used to treat cardiac ischemic injury, pulmonary hypertension and many other diseases, including cancers. Exosomes can be used as a biomarker for disease and cell-free drug delivery system for targeting the cells. Many studies suggest that exosomes can be used as a cell-free vaccine for many diseases. In this chapter, we explore the possibility of future therapeutic potential of exosomes in various cardiovascular diseases.
Keywords: Biomarker; Cardiovascular diseases; Drug delivery; Exosomes; Myocardial infarction; Nanovesicles.
Similar articles
-
Cardiac Progenitor-Cell Derived Exosomes as Cell-Free Therapeutic for Cardiac Repair.Adv Exp Med Biol. 2017;998:207-219. doi: 10.1007/978-981-10-4397-0_14. Adv Exp Med Biol. 2017. PMID: 28936742 Review.
-
The Future of Cardiovascular Regenerative Medicine.Circulation. 2016 Jun 21;133(25):2618-25. doi: 10.1161/CIRCULATIONAHA.115.019214. Circulation. 2016. PMID: 27324357 Free PMC article. Review.
-
Exosomes: Cell-Free Therapy for Cardiovascular Diseases.J Cardiovasc Transl Res. 2020 Oct;13(5):713-721. doi: 10.1007/s12265-020-09966-7. Epub 2020 Apr 24. J Cardiovasc Transl Res. 2020. PMID: 32333198 Review.
-
Therapeutic Effects of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Disease.Adv Exp Med Biol. 2017;998:179-185. doi: 10.1007/978-981-10-4397-0_12. Adv Exp Med Biol. 2017. PMID: 28936740 Review.
-
Exosomes Derived from Embryonic Stem Cells as Potential Treatment for Cardiovascular Diseases.Adv Exp Med Biol. 2017;998:187-206. doi: 10.1007/978-981-10-4397-0_13. Adv Exp Med Biol. 2017. PMID: 28936741 Review.
Cited by
-
Immune Cells and Immunotherapy for Cardiac Injury and Repair.Circ Res. 2021 May 28;128(11):1766-1779. doi: 10.1161/CIRCRESAHA.121.318005. Epub 2021 May 27. Circ Res. 2021. PMID: 34043424 Free PMC article. Review.
-
Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.BMB Rep. 2020 Aug;53(8):400-412. doi: 10.5483/BMBRep.2020.53.8.121. BMB Rep. 2020. PMID: 32731913 Free PMC article. Review.
-
Cardioprotective Strategies After Ischemia-Reperfusion Injury.Am J Cardiovasc Drugs. 2024 Jan;24(1):5-18. doi: 10.1007/s40256-023-00614-4. Epub 2023 Oct 10. Am J Cardiovasc Drugs. 2024. PMID: 37815758 Free PMC article. Review.
-
Ischemia Reperfusion Injury: Mechanisms of Damage/Protection and Novel Strategies for Cardiac Recovery/Regeneration.Int J Mol Sci. 2019 Oct 11;20(20):5024. doi: 10.3390/ijms20205024. Int J Mol Sci. 2019. PMID: 31614414 Free PMC article. Review.
-
Immunomodulation of Myocardial Fibrosis.JACC Basic Transl Sci. 2023 Jun 14;8(11):1477-1488. doi: 10.1016/j.jacbts.2023.03.015. eCollection 2023 Nov. JACC Basic Transl Sci. 2023. PMID: 38093747 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources